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Gas chromatography is able to detect many kinds of sterols simultaneously.  In order
to identify and estimate accurately many kinds of sterols in biological samples by gas
chromatography, it is indispensable to add an internal standard compound into the
analytical samples prior to the analysis.  However, there is no report on a suitable
internal standard compound for the determination of sterols.  In this study, 19-hydroxy-
cholesterol was proved to be a suitable internal standard compound for simultaneous
and quantitative determination of several sterols in various analytical samples by capil-
lary gas chromatography, including the quantitative determination of β-cholestanol in
the human plasma.  Moreover, the excellent condition of gas chromatographic analysis
for quantitative determination of several sterols in various analytical samples was  found.
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There are many reports on the action of in-
testinal flora on several compounds such as
sterols and bile acids, in both in vivo and in vitro
experiments (Björkhem and Gustafsson, 1971;
Eyssen et al., 1973; Uchida et al., 1977; Macdonald
et al.,1983).  However, the kinds of intestinal
flora concerned with the metabolism of sterols
in their host, and so on, have not yet been suffi-
ciently solved.  In order to investigate a number
of unsolved problems, the quantitative determi-
nation of various sterols in feeds, feces, blood
and intestinal contents of experimental animals
needs to be carried out precisely in various ex-
periments using intestinal flora.  Moreover, the
concentration of 5α-cholestan- 3β-ol (β-chole-
stanol), a kind of sterol, in the serum of patients
with  cerebrotendinous xanthomatosis (CTX), a
genetic disorder of the cholesterol metabolism,
increases abnormally (Salen, 1971; Seyama et
al., 1976).  Therefore, analysis of β-cholestanol
in the serum of patients with CTX is useful
from the viewpoint of biochemical diagnosis
(Seyama, 1999).
For the simultaneous determination of vari-
ous sterols and bile acids, gas chromatography,
gas chromatography mass spectrometry (GC-
MS) and/or high performance liquid chroma-
tography (HPLC) are available means.  In com-
parison with the above mentioned instruments,
gas chromatography is a better means for quali-
tative and quantitative determination of sterols
and bile acids, because a gas chromatograph is
very sensitive, is in widespread use in many
laboratories and is simple in its operation.
Determination of sterols by gas chromato-
graphy has been carried out by procedures such
as extraction, hydrolysis, derivatization and in-
jection into the gas chromatograph.  It is impos-
sible to obtain 100% recovery of the sterols in
the sample.  Moreover, recovery may differ from
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Fig. 1.  Capillary  gas chromatogram of several au-
thentic sterols.  The peaks of sterols are as follows:
(  1) Coprostanol,
(  2) 5β-Cholestan-3α-ol,
(  3) Cholesterol,
(  4) β-Cholestanol,
(  5) 19-Hydroxycholesterol (internal standard
compound),
(  6) Campesterol,
(  7) Stigmasterol,
(  8) Lanosterol,
(  9) β-Sitosterol,
(10) Stigmastanol.
See the text on derivatization and gas chromatogra-
phy of sterols.
assay to assay.  Therefore, it is indispensable to
add an internal standard compound into the
analytical samples for correcting the loss of
sterols during the analysis.
We have established a systematic method
for gas chromatographic analysis of bile acids
in biological samples using some internal stan-
dard compounds (Yamaga et al., 2001).  How-
ever, a suitable internal standard compound for
gas chromatographic analysis of sterols has not
yet been reported.
This paper describes the internal standard
compound and the excellent conditions of gas
chromatography for the qualitative and quan-
titative determination of several sterols simul-
taneously using a capillary gas chromatograph.
Experimental Procedures
Materials
Cholesterol, 19-hydroxycholesterol (an internal
standard compound), lanosterol, stigmastanol
and 5β-cholestan-3α-ol were purchased from
Sigma, St. Louis, MO.  Coprostanol was pur-
chased from Gasukuro Kogyo Inc., Tokyo, Japan.
β-Cholestanol and N-trimethylsilylimidazole
were purchased from Tokyo Kasei Kogyo Co.,
Tokyo, Japan.  Campesterol, β-sitosterol and
stigmasterol were purchased from Tama Bio-
chemical Co., LTD, Tokyo, Japan.  Other chemi-
cals were of analytical reagent grade, and all
organic solvents were distilled before use.
Extraction of sterols from analytical sam-
ples
Biological samples (20–50 mg for feces and feed,
and 10–100 µL for human plasma) with and
without 5–10 µg of 19-hydroxycholesterol as an
internal standard compound were hydrolyzed
with 1 mL of 1 M ethanolic sodium hydroxide for
30 min at 80˚C.  After addition of 0.5 mL of dis-
tilled water into the hydrolysate, nonsaponi-
fiable materials (sterols) were extracted with n-
hexane, and then the solvent was evaporated to
dryness.
Derivatization
Extracted sterols were converted into trimethyl-
silyl (TMS) derivatives with N-trimethylsilyl-
imidazole at room temperature overnight or at
80˚C for 30 min.  The sterol-TMS derivatives
were extracted with n-hexane and evaporated to
dryness after washing with distilled water.  An
aliquot of the sterol-TMS derivatives dissolved
in n-hexane was injected into the gas chromato-
graph.
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Fig. 2.  Capillary gas chromatograms of nonsaponifiable fractions with 19-hydroxycholesterol.  (a) mouse
feces, (b) rat feces, (c) mouse and rat feed and (d) human plasma.  I.S. indicates the peak of 19-hydroxychole-
sterol as internal standard compound.  See the text on gas chromatography.
Gas chromatography
The gas chromatograph (Model GC-14A,
Shimadzu, Kyoto, Japan) was equipped with
HiCap CBP-1 capillary column (25 m × 0.25
mm I.D., Shimadzu) and with a solventless in-
jector (Shimadzu).  The capillary column was
programmed at 240˚C for 20 min, from 240˚C
to 260˚C at a rate of 2˚C/min, and then at 260˚C
for 20 min.  Helium was used as the carrier gas.
Capillary gas chromatograms and analytical
data of the sterols were obtained using a com-
puterized data system (Model C-R4A Chromato-
pac, Shimadzu) connected with the gas chroma-
tograph.
Qualitative and quantitative determina-
tion of sterols by gas chromatography
Identification of peaks on the gas chromato-
gram from the specimens was carried out in
agreement with the found and calculated rela-
tive retention time between them and the au-
thentic sterols to the internal standard com-
pound (the retention time of 19-hydroxychole-
sterol = 1.00).  The relative factors for quantita-
tive analysis in the gas chromatography between
the peak area ratio and the weight ratio of each
sterol to 19-hydroxycholesterol were estimated
automatically by injecting a known amount of
authentic sterols and the internal standard com-
pound into the gas chromatograph.
Results and Discussion
In Fig.1, many kinds of authentic sterols, which
are found in specimens of animals and plants,
have been detected separately as peaks of sterol-
TMS derivatives under the excellent conditions
of capillary gas chromatography described in
experimental procedures.  Figure 2 shows capil-
lary gas chromatograms of nonsaponifiable
sterol-TMS derivatives extracted from feed and
feces of mice and rats as well as plasma of hu-
mans under the same conditions of capillary gas
chromatography for analyzing the authentic
sterols.  These results suggest that it is possible
to detect separately many kinds of sterols from
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analytical samples as peaks on a capillary gas
chromatogram, as shown in Fig. 2, under the
same experimental conditions as gas chroma-
tography.
However, in order to accurately identify and
estimate these detectable peaks of sterols from
samples on a gas chromatogram, it is indispens-
able to add an internal standard compound into
the analytical samples before the extraction of
the sterols.
The fundamental requirements for selecting
a suitable internal standard compound for the
determination of sterols by gas chromatography
are as follows —
  i) an internal standard compound must be
added to the analytical samples before the
extraction of sterols, and then the peak of
an internal standard compound must appear
together with peaks of sterol derivatives in
the analytical samples on the same gas
chromatogram;
 ii) the internal standard compound must be
stable.  During the analysis, it must not
decompose into other compounds;
iii) the peak of the internal standard compound
must not pile up on the peaks of sterol
derivatives and other mixed compounds in
the biological sample;
iv) the retention time of the internal standard
compound must not be largely distant from
those of sterols which are being assayed; and
 v) a linear relationship should be maintained
between the measured peak height or area
and the weight of the sterol to the internal
standard compound.
Previously, among 5α-cholestane (Setoguchi
et al., 1974; Ishikawa et al., 1976), 5β-cholestan-
3β-ol (Kasama et al., 1987), 5β-cholestan-3α-
ol (Byun et al.,1988) and 5α-cholestan-3α-ol
(Serizawa et al., 1981), each one has been used
as an internal standard compound for only
quantitative determination of β-cholestanol in
human serum by gas chromatography, GC-MS
and/or HPLC for the biochemical diagnosis of
CTX patients.  But these internal standard com-
pounds are homologous in structure and appear
earlier than many other kinds of sterols such as
campesterol, stigmasterol and lanosterol, etc.,
in gas chromatographic analysis which strongly
differs from the above mentioned 1st and 4th
criteria for internal standard compounds.
During metabolic oxidation of cholesterol,
19-hydroxycholesterol (a particular oxysterol)
is formed (Verhagen et al., 1996).  So far as we
know, there is no report on the detection of 19-
hydroxycholesterol in biological samples.  We
Table 1.  Retention times and relative retention times of internal
standard compounds and several authentic sterols
           Sterols Retention time (min) Relative retention time
(  1) Coprostanol 28.547 0.782
(  2) 5β-Cholestan-3α-ol 29.083 0.797
(  3) Cholesterol 32.367 0.887
(  4) β-Cholestanol 32.795 0.898
(  5) 19-Hydroxycholesterol 36.505 1.000
(  6) Campesterol 37.768 1.035
(  7) Stigmasterol 39.517 1.083
(  8) Lanosterol 42.199 1.156
(  9) β-Sitosterol 43.197 1.183
(10) Stigmastanol 43.834 1.201
Gas chromatographic condition is described in experimental procedures.
Capillary column is HiCap CBP-1 capillary column (25 m × 0.25 mm I.D.).
Sterols are derivatized to TMS-ether.
Relative retention times are expressed relative to 19-hydroxycholesterol.
Internal standard for GC of sterols
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Fig. 3.  Calibration curves of several sterols to 19-hydroxycholesterol for quantitative determination.
were interested in investigating this particular
sterol, 19-hydroxycholesterol, as an internal
standard compound for the quantitative deter-
mination of sterols using a capillary gas chro-
matograph.  The peak of 19-hydroxycholesterol
was in the middle domain between those of the
1st and the last sterols among many sterol peaks
on the gas chromatogram (Fig. 1), and the reten-
tion time of 19-hydroxycholesterol was also
different from those of many authentic sterols
(Table 1).  Besides, there is no peak which over-
laps at the position of the 19-hydroxycholester-
ol peak in all analytical samples.  Calibration
curves for the quantitative determination of
several sterols maintained a linear relationship
going through the origin between the weight
ratio and the peak area ratio of each sterol to 19-
hydroxycholesterol in the range of the measure-
ment (Fig. 3).  From our present experimental
findings we can conclude that 19-hydroxycho-
lesterol fullfills all the requirements of an in-
ternal standard compound.  Using both HiCap
CBP-1 capillary column made with methyl sili-
cone and major authentic sterols found in speci-
mens of animals and plants, excellent condition
for gas chromatography was established as de-
scribed in experimental procedures.
The amount of β-cholestanol in human
serum is usually determined for the biochemical
diagnosis of CTX.  The level of β-cholestanol is
less than 0.2 mg/100 mL on an average in
healthy subjects, and in the serum of CTX pa-
tients the level of β-cholestanol increases about
20–30 times compared with that of healthy
humans (Seyama, 1999).  The cholesterol level
in the serum of CTX patients is usually within
the normal range (130–260 mg/mL) (Salen,
1971).  As we have had no chance to collect blood
samples from CTX patients, different amounts
(1.1, 2.2, 3.1, 5.2, 6.1 and 8.6 µg) of authentic β-
cholestanol were added into 100 µL of healthy
subject plasma, (cholesterol concentration, 219
mg/100 mL in plasma) to prepare artificial plas-
ma samples of CTX patients, and then these
samples were analyzed.  Although the retention
times of β-cholestanol and cholesterol from arti-
ficial plasma samples were adjacent in the gas
chromatogram, the larger cholesterol peak
Peak area of each sterolArea ratio =
Peak area of 19-hydroxycholesterol
Weight of each sterolWeight ratio =
Weight of 19-hydroxycholesterol
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Fig. 4.  Gas chromatograms of nonsaponifiable fractions from healthy subject plasma and  artificial plasma
samples.  (a) Healthy subject plasma (100 µL), (b) Artificial plasma sample (100 µL) with 3.1 µg of authentic
β-cholestanol and (c) Artificial plasma sample (100 µL) with 6.1 µg of authentic β-cholestanol.  The arrow
point indicates the peak of β-cholestanol.  I.S. means the peak of 19-hydroxycholesterol.  See the text on gas
chromatography.
hardly ever overlapped onto the smaller β-
cholestanol one in the same gas chromatogram
(Fig. 4).  Besides, the amount of β-cholestanol in
each artificial plasma sample of CTX  patients
was as expected (Fig. 5).  Cholesterol amount in
the serum of healthy subjects is 130–260 mg/
100 mL on the average.  Cholesterol level in the
serum of CTX patients is usually within this
normal range (Salen, 1971).  But in these ana-
lytical conditions it is uncertain whether or not
the cholesterol peak may pile up on that of β-
cholestanol if the cholesterol level increases
above the normal level.  For this reason, the re-
lation between the amount of cholesterol and β-
cholestanol was investigated.  A sharp peak of
β-cholestanol appeared as a discernible shoul-
der at the end side of the larger cholesterol peak.
When the level of cholesterol was above 300
mg/100 mL, the level of β-cholestanol was de-
termined differently.  In these cases, the level of
β-cholestanol could not be determined accu-
rately, but it could be judged that the level of
measured β-cholestanol in artificial samples
was more than that of β-cholestanol in the plas-
ma of normal subjects.
Due to the large difference between the lev-
el of cholesterol and β-cholestanol in the human
plasma of both normal individuals and patients
with CTX and CTX-like disease, 19-hydroxy-
cholesterol should not be considered as an inter-
nal standard compound only in the case of the
simultaneous determination of cholesterol and
β-cholestanol.  So, it is better to be determined
the cholesterol level by the enzymatic method.
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Fig. 5.  Recovery experiments of β-cholestanol (µg)
in artificial plasma samples (100 µL) prepared from
healthy subject plasma by adding different amount
of authentic β-cholestanol.
As a result, we conclude from our experi-
mental findings that 19-hydroxycholesterol be-
comes an appropriate internal standard com-
pound for the simultaneous determination of
several sterols, including β-cholestanol in the
serum of CTX patients.
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